Medical Properties Trust (MPT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Total portfolio EBITDARM coverage held steady year-over-year at 2.5x, with post-acute assets showing significant growth and general acute care remaining stable.
Q1 2026 net income was $0.05 per share, rebounding from a loss last year, and normalized FFO was $0.14 per share, matching prior year results.
Rent collections from transitioned tenants in Florida, Texas, Arizona, and Louisiana are fully current through April, with ramping expected to reach $1 billion annualized cash rent by year-end.
Behavioral health faced challenges: U.S. operators struggled with staffing, while U.K. operators contended with NHS funding cuts, though demand remains strong in both markets.
Sold two facilities for $31 million and acquired a post-acute facility in Europe for €23 million.
Financial highlights
Normalized FFO for Q1 2026 was $0.14 per share, aided by $0.03–$0.04 per share in one-time cash rent receipts.
Q1 2026 net income was $33 million ($0.05 per share), compared to a net loss of $118 million ($-0.20 per share) in Q1 2025.
Revenues for Q1 2026 were $252 million, up from $245 million in Q1 2025.
G&A expense declined year-over-year due to lower stock compensation expense.
A one-time $44 million tax benefit was recognized from moving seven legal entities into the U.K. restructure.
Outlook and guidance
Confident in achieving over $1 billion in annualized cash rent by year-end, with full contractual rent expected across transitioned assets by 2027.
Expect to begin collecting cash rent from NOR in California in Q2 2026.
Expect continued stabilization and growth in post-acute and general acute segments, with behavioral health recovery timing uncertain.
Management remains focused on addressing upcoming debt maturities flexibly and attractively.
Latest events from Medical Properties Trust
- 2026 proxy covers board elections, auditor ratification, pay-for-performance, and ESG progress.MPT
Proxy filing13 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.MPT
Proxy filing13 Apr 2026 - EBITDARM coverage rose to 2.6x, with profitability and a $1B rent target for 2026.MPT
Q4 20257 Apr 2026 - Q2 2025 featured narrowing losses, rising cash rents, and robust refinancing activity.MPT
Q2 202519 Feb 2026 - Q3 2025 net loss narrowed, revenues rose 5%, and $150M buyback announced.MPT
Q3 202519 Feb 2026 - Q1 2025 delivered a net loss, strong liquidity, and stable rent collections amid restructuring.MPT
Q1 202519 Feb 2026 - Q2 net loss of $320.6M driven by Steward impairments, but $2.5B+ liquidity generated YTD.MPT
Q2 20242 Feb 2026 - Q3 loss of $801M, major asset sales, and re-tenanting set stage for $1B+ cash rent by 2026.MPT
Q3 202415 Jan 2026 - $5.5B in asset sales and debt refinancing strengthen liquidity despite a $4.02/share loss.MPT
Q4 202423 Dec 2025